Moderna Archives -

Pfizer plans considerable 2023 Comirnaty markup

Nicole Raleigh BioNTech, Comirnaty, commercialisation, COVID-19, Moderna, Pfizer, SARS-CoV-2, The People's Vaccine Alliance, vaccines 0 Comment

With US government supplies of Covid vaccines predicted to run out in the first quarter of 2023, it

Pfizer plans considerable 2023 Comirnaty markup

https://pharmaphorum.com/news/pfizer-plans-considerable-2023-comirnaty-markup/

Market Access/ News/ News

US clears Omicron shots from Pfizer, Moderna for children

Phil Taylor BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Moderna, Omicron, paediatric, Pfizer, regulatory 0 Comment

The US authorities have authorised use of two bivalent COVID-19 booster vaccines from Pfizer/BioNTech and Moderna – targeting

US clears Omicron shots from Pfizer, Moderna for children

https://pharmaphorum.com/news/us-clears-omicron-shots-from-pfizer-moderna-for-children/

Digital innovation drives vaccine development

News/ News/ R&D

GSK says RSV vaccine shows 94% efficacy in severe disease

Phil Taylor Bavarian Nordic, GlaxoSmithKline, infectious disease, Johnson & Johnson, Moderna, Pfizer, respiratory syncytial virus, vaccine 0 Comment

GSK’s vaccine against respiratory syncytial virus (RSV) is one of the top prospects in its pipeline, but also

GSK says RSV vaccine shows 94% efficacy in severe disease

https://pharmaphorum.com/news/gsk-says-rsv-vaccine-shows-94-efficacy-in-severe-disease/

News/ News/ News/ Oncology/ R&D

Merck gets on board with Moderna cancer vaccine in $250m deal

Phil Taylor cancer vaccine, immuno-oncology, melanoma, Merck & Co, Moderna, Oncology, partnering, personalised medicine 0 Comment

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised

Merck gets on board with Moderna cancer vaccine in $250m deal

https://pharmaphorum.com/news/merck-gets-on-board-with-moderna-cancer-vaccine-in-250m-deal/

News/ News/ R&D

Pfizer, BioNTech’s mRNA flu vaccine starts phase 3 testing

Phil Taylor BioNTech, CureVac, GlaxoSmithKline, influenza, Moderna, mRNA, Pfizer, Sanofi, Translate Bio, vaccines 0 Comment

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed

Pfizer, BioNTech’s mRNA flu vaccine starts phase 3 testing

https://pharmaphorum.com/news/pfizer-biontechs-mrna-flu-vaccine-starts-phase-3-testing/

Life science leaders sign new ‘Biotech Social Pact’ for Europe

Market Access/ News/ News/ News/ Patients

EMA panel backs COVID-19 vaccines targeting Omicron BA.1

Phil Taylor BioNTech, CHMP, coronavirus, COVID-19, COVID-19 vaccine, EU, Moderna, Omicron, Pfizer 0 Comment

The EMA’s human medicines committee (CHMP) has recommended authorisation of two COVID-19 vaccines from Moderna and Pfizer/BioNTech that

EMA panel backs COVID-19 vaccines targeting Omicron BA.1

https://pharmaphorum.com/news/ema-panel-backs-covid-19-vaccines-targeting-omicron-ba-1/

Market Access/ News/ News/ News/ Sales and Marketing

FDA clears bivalent Omicron shots from Pfizer, Moderna

Phil Taylor BioNTech, coronavirus, COVID-19, COVID-19 vaccine, EUA, Moderna, Omicron, Pfizer 0 Comment

As expected, the FDA has moved quickly to grant emergency use authorisation (EUA) to two new-generation COVID-19 mRNA

FDA clears bivalent Omicron shots from Pfizer, Moderna

https://pharmaphorum.com/news/fda-clears-bivalent-omicron-shots-from-pfizer-moderna/

Automation in the clinical laboratory. Pipetting robot laboratory. Medicine robotics. Research and science background

R&D/ Views & Analysis/ Views and analysis

Expectations rise for gene therapy to change treatment landscape

Ben Hargreaves fda, gene therapy, Moderna, Polaris Market Research 0 Comment

After a recent approval, there are now three gene therapies available on the US market. Though there are

Expectations rise for gene therapy to change treatment landscape

https://pharmaphorum.com/r-d/expectations-rise-for-gene-therapy-to-change-treatment-landscape/

News/ News/ Sales and Marketing

Moderna sues Pfizer/BioNTech over COVID-19 vaccine tech

Phil Taylor BioNTech, coronavirus, COVID-19, COVID-19 vaccine, litigation, Moderna, patent, Pfizer 0 Comment

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts,

Moderna sues Pfizer/BioNTech over COVID-19 vaccine tech

https://pharmaphorum.com/news/moderna-sues-pfizer-biontech-over-covid-19-vaccine-tech/

Trending

Moderna

Login